Catalyst Wire Dossier Catalyst Wire Dossier

TEVIMBRA

tislelizumab-jsgr · BeOne Medicines USA, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for TEVIMBRA, covering 2024-03-13 to 2026-08-25. Get the full timeline:

Most recent: FDA Approved: TEVIMBRA — Supplemental Application (BeOne Medicines USA, Inc.)

See pricing